Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis

Introduction: The effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors on renal outcomes in patients with chronic kidney disease (CKD) were initially demonstrated in recent trials. However, the magnitude of renal benefits for CKD patients with different baseline features and underlying disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Lv, Dan, Zhu, Xiangjun, Wei, Ping, Gui, Yuan, Liu, Shijia, Zhou, Enchao, Zheng, Min, Zhou, Dong, Zhang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591237/
https://www.ncbi.nlm.nih.gov/pubmed/34790672
http://dx.doi.org/10.3389/fmed.2021.728089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591237/
https://www.ncbi.nlm.nih.gov/pubmed/34790672
http://dx.doi.org/10.3389/fmed.2021.728089

Ejemplares similares